{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:16:25Z","timestamp":1770689785822,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pharmacy interventions are a subset of public health interventions and its research is usually performed within the scope of a trial. The economic evaluation of pharmacy interventions requires certain considerations which have some similarities to those of public health interventions and to economic evaluations alongside trials. The objective of this research is to perform an overview of systematic reviews of economic evaluations of pharmacy services and triangulate results with recommendations for economic evaluations of both public health interventions and alongside trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>(1) Exploratory review of recommendations on the economic evaluation of public health interventions, (2) exploratory review of recommendations for conducting economic evaluations alongside trials, (3) overview of systematic reviews of economic evaluations of pharmacy interventions (protocol registered with PROSPERO 2016 outlining information sources, inclusion criteria, appraisal of reviews and synthesis methods).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fourteen systematic reviews containing 75 index publications were included. Reviews reported favorable economic findings for 71% of studies with full economic evaluations. The types of economic analysis are diverse. Two critical quality domains are absent from most reviews. Key findings include the following: certain types of risk of bias, wider scope of study designs, and most economic quality criteria met but some issues unresolved or unclear. Triangulation revealed additional gaps. Limitations include choice of critical quality domains and potential biases in the overview process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Economic evaluations of pharmacy-based public health interventions seem to follow most economic quality criteria, but there are still some issues in certain key areas to improve. These findings may assist in improving the design of pilot trials of economic evaluations in pharmacy, leading to robust evidence for payers. Based on the findings, we propose a methodological approach for the economic evaluation of pharmacy-based public health interventions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>PROSPERO<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42016032768\">CRD42016032768<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1186\/s13643-019-1177-3","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T09:03:14Z","timestamp":1573462994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["An overview of systematic reviews of economic evaluations of pharmacy-based public health interventions: addressing methodological challenges"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-5473","authenticated-orcid":false,"given":"Suzete","family":"Costa","sequence":"first","affiliation":[]},{"given":"Maria","family":"Cary","sequence":"additional","affiliation":[]},{"given":"Dennis K.","family":"Helling","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"C\u00e9u","family":"Mateus","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"1177_CR1","volume-title":"Methods for the development of NICE public health guidance","author":"National Institute for Health and Clinical Excellence","year":"2012","unstructured":"National Institute for Health and Clinical Excellence. Methods for the development of NICE public health guidance. 3rd ed. London: NICE; 2012.","edition":"3"},{"key":"1177_CR2","doi-asserted-by":"crossref","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: new guidance. MRC; 2008.","DOI":"10.1136\/bmj.a1655"},{"key":"1177_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1345\/aph.1K617","volume":"42","author":"AS Roberts","year":"2008","unstructured":"Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42:861\u20138.","journal-title":"Ann Pharmacother"},{"key":"1177_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/1077558712459215","volume":"70","author":"SJ Blalock","year":"2013","unstructured":"Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O'Connor SK. The effect of community pharmacy-based interventions on patient health outcomes: a systematic review. Med Care Res Rev. 2013;70:235\u201366.","journal-title":"Med Care Res Rev"},{"key":"1177_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13063-015-0755-5","volume":"16","author":"H McMullen","year":"2015","unstructured":"McMullen H, Griffiths C, Leber W, Greenhalgh T. Explaining high and low performers in complex intervention trials: a new model based on diffusion of innovations theory. Trials. 2015;16:242. https:\/\/doi.org\/10.1186\/s13063-015-0755-5.","journal-title":"Trials"},{"issue":"7","key":"1177_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/08870440701544437","volume":"23","author":"R Cooke","year":"2008","unstructured":"Cooke R, French DP. How well do the theory of reasoned action and theory of planned behaviour predict intentions and attendance at screening programmes? A meta-analysis. Psychol Health. 2008;23(7):745\u201365.","journal-title":"Psychol Health"},{"issue":"5","key":"1177_CR7","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/dc13-1828","volume":"37","author":"LS Mayberry","year":"2014","unstructured":"Mayberry LS, Osborn CY. Empirical validation of the information\u2013motivation\u2013behavioral skills model of diabetes medication adherence: a framework for intervention. Diabetes Care. 2014;37(5):1246\u201353.","journal-title":"Diabetes Care"},{"issue":"1","key":"1177_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2010.06.030","volume":"91","author":"MK Baker","year":"2011","unstructured":"Baker MK, Simpson K, Lloyd B, Bauman AE, Singh MA. Behavioral strategies in diabetes prevention programs: a systematic review of randomized controlled trials. Diabetes Res Clin Pract. 2011;91(1):1\u201312. https:\/\/doi.org\/10.1016\/j.diabres.2010.06.030.","journal-title":"Diabetes Res Clin Pract"},{"key":"1177_CR9","doi-asserted-by":"publisher","first-page":"h1258","DOI":"10.1136\/bmj.h1258","volume":"350","author":"GF Moore","year":"2015","unstructured":"Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258. https:\/\/doi.org\/10.1136\/bmj.h1258 Available from: http:\/\/www.bmj.com\/content\/bmj\/350\/bmj.h1258.full.pdf.","journal-title":"BMJ"},{"key":"1177_CR10","doi-asserted-by":"publisher","DOI":"10.1787\/9789264183896-en","volume-title":"Health at a glance","author":"OECD (2012)","year":"2012","unstructured":"OECD (2012). Health at a glance. Europe: OECD publishing; 2012. https:\/\/doi.org\/10.1787\/9789264183896-en. [consultado em 10-06-2013]"},{"key":"1177_CR11","volume-title":"Briefing paper: economic appraisal of public health interventions","author":"MP Kelly","year":"2005","unstructured":"Kelly MP, McDaid D, Ludbrook A, Powell J. Briefing paper: economic appraisal of public health interventions. London: NHS Health Development Agency; 2005."},{"key":"1177_CR12","volume-title":"Principles of pharmacoeconomics","author":"JL Bootman","year":"1996","unstructured":"Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. 2nd ed. Cincinnati: Harvey Whitney Books; 1996.","edition":"2"},{"key":"1177_CR13","volume-title":"Evaluating and justifying clinical pharmacy services. In: pharmacoeconomics and outcomes: applications for patient care","author":"G Schumock","year":"2003","unstructured":"Schumock G, Butler M. Evaluating and justifying clinical pharmacy services. In: pharmacoeconomics and outcomes: applications for patient care. 2nd ed. Kansas City: American College of Clinical Pharmacy; 2003.","edition":"2"},{"issue":"10 Pt 2","key":"1177_CR14","doi-asserted-by":"publisher","first-page":"243S","DOI":"10.1592\/phco.20.16.243S.35018","volume":"20","author":"GT Schumock","year":"2000","unstructured":"Schumock GT. Methods to assess the economic outcomes of clinical pharmacy services. Pharmacotherapy. 2000;20(10 Pt 2):243S\u201352S.","journal-title":"Pharmacotherapy"},{"key":"1177_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.healthpol.2009.07.012","volume":"93","author":"H Weatherly","year":"2009","unstructured":"Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy. 2009;93:85\u201392.","journal-title":"Health Policy"},{"key":"1177_CR16","unstructured":"Honeycutt AA, Clayton L, Khavjou O, Finkelstein EA, Prabhu M, Blitstein JL, et al. Guide to analyzing the cost-effectiveness of community public health prevention approaches: CDC US Department of Health and Human Services; 2006."},{"issue":"1","key":"1177_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1524-4733.2005.03065.x","volume":"8","author":"AK O\u2019Sullivan","year":"2005","unstructured":"O\u2019Sullivan AK, Thompson D, Drummond MF. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? Value Health. 2005;8(1):67\u201379.","journal-title":"Value Health"},{"key":"1177_CR18","doi-asserted-by":"publisher","first-page":"d1548","DOI":"10.1136\/bmj.d1548","volume":"342","author":"S Petrou","year":"2011","unstructured":"Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011;342:d1548.","journal-title":"BMJ"},{"key":"1177_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/ajhp\/54.5.554","volume":"54","author":"JA Johnson","year":"1997","unstructured":"Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health-Syst Pharm. 1997;54:554\u20138.","journal-title":"Am J Health-Syst Pharm"},{"issue":"10","key":"1177_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/MLR.0b013e3181e57962","volume":"48","author":"MA Chisholm-Burns","year":"2010","unstructured":"Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, et al. US pharmacists\u2019 effect as team members on patient care. Systematic review and meta-analyses. Med Care. 2010;48(10):923\u201333.","journal-title":"Med Care"},{"key":"1177_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.healthpol.2013.04.003","volume":"111","author":"E Mossialos","year":"2013","unstructured":"Mossialos E, Naci H, Courtin E. Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? Health Policy. 2013;111:135\u201348.","journal-title":"Health Policy"},{"key":"1177_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11096-015-0137-9","volume":"37","author":"I Rotta","year":"2015","unstructured":"Rotta I, Salgado TM, Silva ML, Correr CJ, Llimos F. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000\u20132010). Int J Clin Pharm. 2015;37:687\u201397.","journal-title":"Int J Clin Pharm"},{"key":"1177_CR23","unstructured":"Public Health England. Consolidating and developing the evidence base and research for community pharmacy\u2019s contribution to public health: a progress report from Task Group 3 of the Pharmacy and Public Health Forum. London: PHE; 2014. p. 11-14. Available at: https:\/\/www.gov.uk\/government\/publications\/consolidating-and-developing-the-evidence-base-and-research-for-community-pharmacys-contribution-to-public-health."},{"key":"1177_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s40273-014-0197-z","volume":"32","author":"RA Elliott","year":"2014","unstructured":"Elliott RA, Putman K, Davies J. A review of the methodological challenges in assessing the cost effectiveness of pharmacist interventions. PharmacoEconomics. 2014;32:1185\u201399.","journal-title":"PharmacoEconomics"},{"key":"1177_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S1744133109004903","volume":"4","author":"R Cookson","year":"2009","unstructured":"Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Econ Policy Law. 2009;4:231\u201345.","journal-title":"Health Econ Policy Law"},{"key":"1177_CR26","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/ijerph7052274","volume":"7","author":"PK Lorgelly","year":"2010","unstructured":"Lorgelly PK, Lawson KD, Fenwick EAL, Briggs AH. Outcome measurement in economic evaluations of public health interventions: a role for the capability approach? Int J Environ Res Public Health. 2010;7:2274\u201389.","journal-title":"Int J Environ Res Public Health"},{"key":"1177_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2191-1991-2-17","volume":"2","author":"K Marsh","year":"2012","unstructured":"Marsh K, Phillips CJ, Fordham R, Bertranou E, Hale J. Estimating cost-effectiveness in public health: a summary of modelling and valuation methods. Heal Econ Rev. 2012;2:17.","journal-title":"Heal Econ Rev"},{"key":"1177_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1186\/1471-2458-13-1001","volume":"13","author":"RT Edwards","year":"2013","unstructured":"Edwards RT, Charles JM, Lloyd-Williams H. Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues. BMC Public Health. 2013;13:1001.","journal-title":"BMC Public Health"},{"key":"1177_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/pubmed\/fdt080","volume":"36","author":"AFG Alayli-Goebbels","year":"2013","unstructured":"Alayli-Goebbels AFG, Evers SMAA, Alexeeva D, Ament AJHA, de Vries NK, Tilly JC, et al. A review of economic evaluations of behavior change interventions: setting an agenda for research methods and practice. J Public Health. 2013;36:336\u201344 [epub ahead of print].","journal-title":"J Public Health"},{"key":"1177_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","volume":"18","author":"SD Ramsey","year":"2015","unstructured":"Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis alongside clinical trials II \u2013 an ISPOR Good Research Practices Task Force report. Value Health. 2015;18:161\u201372.","journal-title":"Value Health"},{"key":"1177_CR31","unstructured":"Becker LA, Oxman AD. Chapter 22: overviews of reviews. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0: The Cochrane Collaboration; 2011. Available from www.handbook.cochrane.org. (updated March 2011)."},{"key":"1177_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2288-11-15","volume":"11","author":"V Smith","year":"2011","unstructured":"Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11:15.","journal-title":"BMC Med Res Methodol"},{"key":"1177_CR33","unstructured":"The Joanna Briggs Institute. Joanna Briggs Institute reviewers\u2019 manual 2014 \u2013 methodology for JBI umbrella reviews: The Joanna Briggs Institute; 2014. Available from: http:\/\/joannabriggs.org\/assets\/docs\/sumari\/ReviewersManual-Methodology-JBI_Umbrella%20Reviews-2014.pdf"},{"key":"1177_CR34","unstructured":"Centre for Reviews and Dissemination. Systematic reviews. CRD\u2019s guidance for undertaking reviews in healthcare. York: CRD University of York, 2009. Available from: https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf."},{"key":"1177_CR35","unstructured":"Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, Mallender J, McDaid D, Vale L, Walker D. Chapter 15: incorporating economics evidence. In: JPT H, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0: The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org. (updated March 2011)."},{"key":"1177_CR36","unstructured":"Armstrong R, Waters E, Doyle J. Chapter 21: reviews in health promotion and public health. In: JPT H, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0: The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org. (updated March 2011)."},{"key":"1177_CR37","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(6): e1000097. doi:https:\/\/doi.org\/10.1371\/journal.pmed1000097. Available from: http:\/\/www.plosmedicine.org\/article\/fetchObject.action?uri=info:doi\/10.1371\/journal.pmed.1000097&representation=PDF","DOI":"10.1371\/journal.pmed1000097"},{"key":"1177_CR38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","volume":"67","author":"D Pieper","year":"2014","unstructured":"Pieper D, Antoine SL, Mathes T, Neugebauer EAM, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014;67:368\u201375.","journal-title":"J Clin Epidemiol"},{"key":"1177_CR39","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"B Shea","year":"2017","unstructured":"Shea B, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"BMJ"},{"key":"1177_CR40","volume-title":"What study designs should be included in an EPOC review? EPOC resources for review authors","author":"Cochrane Effective Practice and Organisation of Care (EPOC)","year":"2017","unstructured":"Cochrane Effective Practice and Organisation of Care (EPOC). What study designs should be included in an EPOC review? EPOC resources for review authors, 2017. Available at: http:\/\/epoc.cochrane.org\/epoc-specific-resources-review-authors"},{"key":"1177_CR41","volume-title":"Suggested risk of bias criteria for EPOC reviews. EPOC resources for review authors","author":"Cochrane Effective Practice and Organisation of Care (EPOC)","year":"2017","unstructured":"Cochrane Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC resources for review authors, 2017. Available at: http:\/\/epoc.cochrane.org\/resources\/epoc-resources-review-authors"},{"key":"1177_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","volume":"16","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS)\u2014explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16:231\u201350.","journal-title":"Value Health"},{"issue":"1","key":"1177_CR43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/heapro\/dai025","volume":"21","author":"Shuhong Wang","year":"2005","unstructured":"Wang S, Moss JR, Hiller JE. Applicability and transferability of interventions in evidence-based public health. Health Promot Int. 2005;21(1). https:\/\/doi.org\/10.1093\/heapro\/dai025.","journal-title":"Health Promotion International"},{"issue":"6","key":"1177_CR44","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/j.1875-9114.1996.tb03049.x","volume":"16","author":"GT Schumock","year":"1996","unstructured":"Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy services - 1988-1995. Pharmacotherapy. 1996;16(6):1188\u2013208.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1177_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1592\/phco.23.1.113.31910","volume":"23","author":"GT Schumock","year":"2003","unstructured":"Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003;23(1):113\u201332.","journal-title":"Pharmacotherapy"},{"issue":"11","key":"1177_CR46","first-page":"285e","volume":"28","author":"A Perez","year":"2008","unstructured":"Perez A, Doloresco F, Hoffman JM, Meek PD, Touchette DR, Vermeulen LC, Schumock GT. Economic evaluations of clinical pharmacy services: 2001\u20132005. Pharmacotherapy. 2008;28(11):285e\u2013323e.","journal-title":"Pharmacotherapy"},{"issue":"19","key":"1177_CR47","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.2146\/ajhp100077","volume":"67","author":"MA Chisholm-Burns","year":"2010","unstructured":"Chisholm-Burns MA, Graff Zivin JS, Lee JK, Spivey CA, Slack M, Herrier RN, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Health Syst Pharm. 2010;67(19):1624\u201334.","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"1177_CR48","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/phar.1414","volume":"34","author":"D Touchette","year":"2014","unstructured":"Touchette D, Doloresco F, Suda K, Perez A, Turner S, Jalundhwala Y, et al. Economic evaluations of clinical pharmacy services: 2006-2010. Pharmacotherapy. 2014;34(8):771\u201393. https:\/\/doi.org\/10.1002\/phar.1414.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"1177_CR49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.18553\/jmcp.2013.19.5.408","volume":"19","author":"A Altowaijri","year":"2013","unstructured":"Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm. 2013;19(5):408\u201316.","journal-title":"J Manag Care Pharm"},{"key":"1177_CR50","doi-asserted-by":"publisher","first-page":"e009828","DOI":"10.1136\/bmjopen-2015-009828","volume":"6","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Todd A, O\u2019Malley C, Moore HJ, Husband AK, Bambra C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6:e009828. https:\/\/doi.org\/10.1136\/bmjopen-2015-009828.","journal-title":"BMJ Open"},{"key":"1177_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/dme.12976","volume":"33","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yeo QQ, Ko Y. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review. Diabet Med. 2016;33:421\u20137. https:\/\/doi.org\/10.1111\/dme.12976.","journal-title":"Diabet Med"},{"key":"1177_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1109-9666(16)30012-4","volume":"57","author":"A Peletidi","year":"2016","unstructured":"Peletidi A, Nabhani-Gebara S, Kayyali R. Smoking cessation support services at community pharmacies in the UK: a systematic review. Hell J Cardiol. 2016;57:7\u201315.","journal-title":"Hell J Cardiol"},{"key":"1177_CR53","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.healthpol.2016.09.013","volume":"120","author":"C Perraudin","year":"2016","unstructured":"Perraudin C, Bugnon O, Pelletier-Fleury N. Expanding professional pharmacy services in European community setting: is it cost-effective? A systematic review for health policy considerations. Health Policy. 2016;120:1350\u201362.","journal-title":"Health Policy"},{"key":"1177_CR54","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/jcpt.12453","volume":"41","author":"ZWR Loh","year":"2016","unstructured":"Loh ZWR, Cheen MHH, Wee HL. Humanistic and economic outcomes of pharmacist-provided medication review in the community-dwelling elderly: a systematic review and meta-analysis. J Clin Pharm Ther. 2016;41:621\u201333. https:\/\/doi.org\/10.1111\/jcpt.12453.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"1177_CR55","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/14737167.2016.1259071","volume":"16","author":"A Malet-Larrea","year":"2016","unstructured":"Malet-Larrea A, Garc\u00eda-C\u00e1rdenas V, S\u00e1ez-Benito L, Benrimoj SI, Calvo B, Goyenechea E. Cost-effectiveness of professional pharmacy services in community pharmacy: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2016. https:\/\/doi.org\/10.1080\/14737167.2016.1259071.","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"key":"1177_CR56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/1060028016667741","volume":"16","author":"T Gammie","year":"2016","unstructured":"Gammie T, Vogler S, Babar Z. Economic evaluation of hospital and community pharmacy services: a review of the literature (2010-2015). Ann Pharmacother. 2016;16:747\u201358. https:\/\/doi.org\/10.1177\/1060028016667741.","journal-title":"Ann Pharmacother"},{"key":"1177_CR57","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","volume":"342","author":"J Concato","year":"2000","unstructured":"Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887\u201392.","journal-title":"N Engl J Med"},{"key":"1177_CR58","volume-title":"Effective public health practice project quality assessment tool for quantitative studies","author":"Effective Public Health Practice Project","year":"1998","unstructured":"Effective Public Health Practice Project. Effective public health practice project quality assessment tool for quantitative studies. 1998. http:\/\/www.ephpp.ca\/tools.html."},{"key":"1177_CR59","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"1177_CR60","first-page":"1","volume-title":"Economic evaluation of pharmacy services","author":"C Jommy","year":"2017","unstructured":"Jommy C. An introduction to economic evaluation of health care programs. In: Babar Z-U-D, editor. Economic evaluation of pharmacy services. London: Academic; 2017. p. 1\u20139."},{"key":"1177_CR61","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/B978-0-12-803659-4.00005-9","volume-title":"Economic evaluation of pharmacy services","author":"JA Whitty","year":"2017","unstructured":"Whitty JA. Design principles for economic evaluations in pharmacy. In: Babar Z-U-D, editor. Economic evaluation of pharmacy services. London: Academic; 2017. p. 121\u201332."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1177-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-019-1177-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-019-1177-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T17:49:02Z","timestamp":1722016142000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-019-1177-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1186\/s13643-019-1177-3","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants performed by any of the authors. No identifying information about participants is available in the article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SC was employed by the National Association of Pharmacies (ANF)\u00a0at the time of this research. MC is employed by the ANF. DKH has given talks on US innovative pharmacist-led interventions at conferences in Portugal for which travel and accommodation costs have been borne by the ANF. The ANF had no role in the concept or design of this paper, in the collection, analysis, and interpretation of data, or in the writing of or commenting on this paper or previous versions of it. The other coauthors declare that they have no known conflicts of interest. None of the authors was involved in any of the included reviews or in individual studies of this overview.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}